(Q38557085)

4 September 2017

title

Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits (English)

1 reference

4 September 2017

1 reference

Hashizoe M

1

1 reference

4 September 2017

Ogura Y

2

1 reference

4 September 2017

Takanashi T

3

1 reference

4 September 2017

Kunou N

4

1 reference

4 September 2017

Honda Y

5

1 reference

4 September 2017

Ikada Y

6

1 reference

4 September 2017

publication date

1 July 1997

1 reference

4 September 2017

1 reference

4 September 2017

volume

16

1 reference

4 September 2017

issue

7

1 reference

4 September 2017

page(s)

633-639

1 reference

Cytomegalovirus retinitis and acquired immunodeficiency syndrome

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

Survival of patients with the acquired immune deficiency syndrome after development of cytomegalovirus retinopathy. UCLA CMV Retinopathy Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis. Use of an intravitreal device

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

Scleral plug of biodegradable polymers for controlled drug release in the vitreous

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

Implantable biodegradable polymeric device in the treatment of experimental proliferative vitreoretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

Ocular Disorders Associated with a new Severe Acquired Cellular Immunodeficiency Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

Clinical and histologic findings in opportunistic ocular infections. Part of a new syndrome of acquired immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

Acquired immune deficiency syndrome. Ocular manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

Ophthalmic Involvement in Acquired Immunodeficiency Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

Treatment of cytomegalovirus retinopathy with ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

Treatment of cytomegalovirus retinitis with ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U)

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

Intravitreal injection of liposome-encapsulated ganciclovir in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

Intravitreal Sustained-Release Ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine: a new potent and selective antiherpes agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.7.633.5063

10.1076/CEYR.16.7.633.5063

21 January 2018

Identifiers

DOI

1 reference

4 September 2017

1 reference